Kintegral Advisory LLC Has $2.92 Million Stock Position in MetLife, Inc. (NYSE:MET)

Kintegral Advisory LLC decreased its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 32.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 36,402 shares of the financial services provider's stock after selling 17,854 shares during the quarter. Kintegral Advisory LLC's holdings in MetLife were worth $2,923,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in MET. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of MetLife by 1.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider's stock valued at $63,559,000 after purchasing an additional 12,723 shares during the period. Sei Investments Co. raised its stake in shares of MetLife by 7.1% during the fourth quarter. Sei Investments Co. now owns 435,847 shares of the financial services provider's stock worth $35,687,000 after purchasing an additional 28,848 shares during the last quarter. Ritholtz Wealth Management lifted its holdings in shares of MetLife by 52.1% in the 1st quarter. Ritholtz Wealth Management now owns 9,355 shares of the financial services provider's stock valued at $751,000 after buying an additional 3,204 shares during the period. Charles Schwab Investment Management Inc. increased its stake in MetLife by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider's stock valued at $320,430,000 after purchasing an additional 30,187 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC purchased a new stake in shares of MetLife in the fourth quarter valued at about $301,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have commented on MET shares. Cowen restated a "buy" rating on shares of MetLife in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods reduced their price objective on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Wells Fargo & Company increased their price objective on MetLife from $91.00 to $94.00 and gave the stock an "overweight" rating in a report on Tuesday, May 6th. Finally, Piper Sandler upped their price target on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $94.17.

MetLife Price Performance

NYSE MET traded down $0.65 on Friday, reaching $79.50. The company's stock had a trading volume of 1,617,752 shares, compared to its average volume of 3,365,826. The business has a 50-day moving average price of $78.65 and a 200 day moving average price of $80.11. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.55. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The firm has a market cap of $53.37 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 0.68 and a beta of 0.85.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). The business had revenue of $18.57 billion during the quarter, compared to the consensus estimate of $18.06 billion. MetLife had a net margin of 6.08% and a return on equity of 20.89%. The firm's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period last year, the business posted $1.83 EPS. Sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 6th were issued a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend was Tuesday, May 6th. This is a boost from MetLife's previous quarterly dividend of $0.55. MetLife's payout ratio is 36.91%.

MetLife announced that its board has initiated a stock buyback plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.